Regulatory News
Monday, July 25, 2016
BRIEF-Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
* On July 15, co entered into a settlement satisfaction
amendment with Livzon Mabpharm Inc - SEC filing
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment